aluates Reports

$ 0.0

Automative

Global Endoglycosidases Market Outlook, In‑Depth Analysis & Forecast to 2031

Published Date: November 2025

Report Code: QYRE-Auto-22R17006

Global Endoglycosidases Market Research Report 2024

BUY CHAPTERS

Global Endoglycosidases Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-22R17006

Report

November 2025

Pages:156

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

CD BioGlyco

NEB

Ludger Ltd.

Promega

Leadgene Biomedical

Agilent

Merck

MyBioSource

Biosynth

Creative Enzymes

RHINO BIO

Endoglycosidases Market

The global Endoglycosidases market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Endoglycosidases are a class of enzymes that catalyze the hydrolysis of glycosidic bonds within glycan structures, leading to the cleavage of glycan molecules at specific sites. These enzymes are commonly used in glycobiology research to modify or analyze glycan structures in proteins or other biomolecules.

From a downstream perspective, Glycan Sequencing accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

Endoglycosidases leading manufacturers including CD BioGlyco, NEB, Ludger, Promega, Leadgene Biomedical, Agilent, Merck, MyBiosource, Biosynth, Creative-Enzymes, etc., dominate supply; the top five capture approximately % of global revenue, with CD BioGlyco leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Endoglycosidases market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Scope of Endoglycosidases Market Report

Report Metric	Details
Report Name	Endoglycosidases Market
Segment by Type	Endoglycosidase F1 Endoglycosidase F2 Endoglycosidase F3 Endoglycosidase H Others
Segment by Application	Glycan Sequencing Glycoprotein Production Others
Production by Region	North America Europe China Japan
Sales by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	CD BioGlyco, NEB, Ludger, Promega, Leadgene Biomedical, Agilent, Merck, MyBiosource, Biosynth, Creative-Enzymes, Rhino Bio
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the Endoglycosidases study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Endoglycosidases Market report?

Ans: The main players in the Endoglycosidases Market are CD BioGlyco, NEB, Ludger, Promega, Leadgene Biomedical, Agilent, Merck, MyBiosource, Biosynth, Creative-Enzymes, Rhino Bio

What are the Application segmentation covered in the Endoglycosidases Market report?

Ans: The Applications covered in the Endoglycosidases Market report are Glycan Sequencing, Glycoprotein Production, Others

What are the Type segmentation covered in the Endoglycosidases Market report?

Ans: The Types covered in the Endoglycosidases Market report are Endoglycosidase F1, Endoglycosidase F2, Endoglycosidase F3, Endoglycosidase H, Others

1 Study Coverage

1.1 Introduction to Endoglycosidases: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Endoglycosidases Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Endoglycosidase F1

1.2.3 Endoglycosidase F2

1.2.4 Endoglycosidase F3

1.2.5 Endoglycosidase H

1.2.6 Others

1.3 Market Segmentation by Application

1.3.1 Global Endoglycosidases Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Glycan Sequencing

1.3.3 Glycoprotein Production

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Endoglycosidases Revenue Estimates and Forecasts 2020-2031

2.2 Global Endoglycosidases Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global Endoglycosidases Sales Estimates and Forecasts 2020-2031

2.4 Global Endoglycosidases Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

3 Global Production Analysis

3.1 Global Endoglycosidases Production Capacity and Utilization Rates (2020–2031)

3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)

3.3 Regional Production Dynamics

3.3.1 Historic Production by Region (2020-2025)

3.3.2 Forecasted Production by Region (2026-2031)

3.3.3 Production Market Share by Region (2020-2031)

3.3.4 Regulatory and Trade Policy Impact on Production

3.3.5 Production Capacity Enablers and Constraints

3.4 Key Regional Production Hubs

3.4.1 North America

3.4.2 Europe

3.4.3 China

3.4.4 Japan

4 Competition by Manufacturers

4.1 Global Endoglycosidases Sales by Manufacturers

4.1.1 Global Sales Volume by Manufacturers (2020-2025)

4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

4.2 Global Endoglycosidases Manufacturer Revenue Rankings and Tiers

4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

4.3 Manufacturer Profitability Profiles and Pricing Strategies

4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

4.3.2 Manufacturer-Level Price Trends (2020-2025)

4.4 Key Manufacturers Manufacturing Base and Headquarters

4.5 Main Product Type Market Size by Manufacturers

4.5.1 Endoglycosidase F1 Market Size by Manufacturers

4.5.2 Endoglycosidase F2 Market Size by Manufacturers

4.5.3 Endoglycosidase F3 Market Size by Manufacturers

4.5.4 Endoglycosidase H Market Size by Manufacturers

4.5.5 Others Market Size by Manufacturers

4.6 Global Endoglycosidases Market Concentration and Dynamics

4.6.1 Global Market Concentration (CR5 and HHI)

4.6.2 Entrant/Exit Impact Analysis

4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

5 Global Product Segmentation Analysis

5.1 Global Endoglycosidases Sales Performance by Type

5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

5.1.2 Global Sales Market Share by Type (2020-2031)

5.2 Global Endoglycosidases Revenue Trends by Type

5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

5.2.2 Global Revenue Market Share by Type (2020-2031)

5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

5.4 Product Technology Differentiation

5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

5.5.1 High-Growth Niches and Adoption Drivers

5.5.2 Profitability Hotspots and Cost Drivers

5.5.3 Substitution Threats

6 Global Downstream Application Analysis

6.1 Global Endoglycosidases Sales by Application

6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

6.1.2 Global Sales Market Share by Application (2020-2031)

6.1.3 High-Growth Application Identification

6.1.4 Emerging Application Case Studies

6.2 Global Endoglycosidases Revenue by Application

6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

6.2.2 Revenue Market Share by Application (2020-2031)

6.3 Global Pricing Dynamics by Application (2020-2031)

6.4 Downstream Customer Analysis

6.4.1 Top Customers by Region

6.4.2 Top Customers by Application

7 North America

7.1 North America Sales Volume and Revenue (2020-2031)

7.2 North America Key Manufacturers Sales Revenue in 2024

7.3 North America Endoglycosidases Sales and Revenue by Type (2020-2031)

7.4 North America Endoglycosidases Sales and Revenue by Application (2020-2031)

7.5 North America Growth Accelerators and Market Barriers

7.6 North America Endoglycosidases Market Size by Country

7.6.1 North America Revenue by Country

7.6.2 North America Sales Trends by Country

7.6.3 US

7.6.4 Canada

7.6.5 Mexico

8 Europe

8.1 Europe Sales Volume and Revenue (2020-2031)

8.2 Europe Key Manufacturers Sales Revenue in 2024

8.3 Europe Endoglycosidases Sales and Revenue by Type (2020-2031)

8.4 Europe Endoglycosidases Sales and Revenue by Application (2020-2031)

8.5 Europe Growth Accelerators and Market Barriers

8.6 Europe Endoglycosidases Market Size by Country

8.6.1 Europe Revenue by Country

8.6.2 Europe Sales Trends by Country

8.6.3 Germany

8.6.4 France

8.6.5 U.K.

8.6.6 Italy

8.6.7 Russia

9 Asia-Pacific

9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

9.3 Asia-Pacific Endoglycosidases Sales and Revenue by Type (2020-2031)

9.4 Asia-Pacific Endoglycosidases Sales and Revenue by Application (2020-2031)

9.5 Asia-Pacific Endoglycosidases Market Size by Region

9.5.1 Asia-Pacific Revenue by Region

9.5.2 Asia-Pacific Sales Trends by Region

9.6 Asia-Pacific Growth Accelerators and Market Barriers

9.7 Southeast Asia

9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand

9.8 China

9.9 Japan

9.10 South Korea

9.11 China Taiwan

9.12 India

10 Central and South America

10.1 Central and South America Sales Volume and Revenue (2020-2031)

10.2 Central and South America Key Manufacturers Sales Revenue in 2024

10.3 Central and South America Endoglycosidases Sales and Revenue by Type (2020-2031)

10.4 Central and South America Endoglycosidases Sales and Revenue by Application (2020-2031)

10.5 Central and South America Investment Opportunities and Key Challenges

10.6 Central and South America Endoglycosidases Market Size by Country

10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 Brazil

10.6.3 Argentina

11 Middle East and Africa

11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

11.3 Middle East and Africa Endoglycosidases Sales and Revenue by Type (2020-2031)

11.4 Middle East and Africa Endoglycosidases Sales and Revenue by Application (2020-2031)

11.5 Middle East and Africa Investment Opportunities and Key Challenges

11.6 Middle East and Africa Endoglycosidases Market Size by Country

11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

11.6.2 GCC Countries

11.6.3 Turkey

11.6.4 Egypt

11.6.5 South Africa

12 Corporate Profile

12.1 CD BioGlyco

12.1.1 CD BioGlyco Corporation Information

12.1.2 CD BioGlyco Business Overview

12.1.3 CD BioGlyco Endoglycosidases Product Models, Descriptions and Specifications

12.1.4 CD BioGlyco Endoglycosidases Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.1.5 CD BioGlyco Endoglycosidases Sales by Product in 2024

12.1.6 CD BioGlyco Endoglycosidases Sales by Application in 2024

12.1.7 CD BioGlyco Endoglycosidases Sales by Geographic Area in 2024

12.1.8 CD BioGlyco Endoglycosidases SWOT Analysis

12.1.9 CD BioGlyco Recent Developments

12.2 NEB

12.2.1 NEB Corporation Information

12.2.2 NEB Business Overview

12.2.3 NEB Endoglycosidases Product Models, Descriptions and Specifications

12.2.4 NEB Endoglycosidases Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.2.5 NEB Endoglycosidases Sales by Product in 2024

12.2.6 NEB Endoglycosidases Sales by Application in 2024

12.2.7 NEB Endoglycosidases Sales by Geographic Area in 2024

12.2.8 NEB Endoglycosidases SWOT Analysis

12.2.9 NEB Recent Developments

12.3 Ludger

12.3.1 Ludger Corporation Information

12.3.2 Ludger Business Overview

12.3.3 Ludger Endoglycosidases Product Models, Descriptions and Specifications

12.3.4 Ludger Endoglycosidases Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.3.5 Ludger Endoglycosidases Sales by Product in 2024

12.3.6 Ludger Endoglycosidases Sales by Application in 2024

12.3.7 Ludger Endoglycosidases Sales by Geographic Area in 2024

12.3.8 Ludger Endoglycosidases SWOT Analysis

12.3.9 Ludger Recent Developments

12.4 Promega

12.4.1 Promega Corporation Information

12.4.2 Promega Business Overview

12.4.3 Promega Endoglycosidases Product Models, Descriptions and Specifications

12.4.4 Promega Endoglycosidases Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.4.5 Promega Endoglycosidases Sales by Product in 2024

12.4.6 Promega Endoglycosidases Sales by Application in 2024

12.4.7 Promega Endoglycosidases Sales by Geographic Area in 2024

12.4.8 Promega Endoglycosidases SWOT Analysis

12.4.9 Promega Recent Developments

12.5 Leadgene Biomedical

12.5.1 Leadgene Biomedical Corporation Information

12.5.2 Leadgene Biomedical Business Overview

12.5.3 Leadgene Biomedical Endoglycosidases Product Models, Descriptions and Specifications

12.5.4 Leadgene Biomedical Endoglycosidases Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.5.5 Leadgene Biomedical Endoglycosidases Sales by Product in 2024

12.5.6 Leadgene Biomedical Endoglycosidases Sales by Application in 2024

12.5.7 Leadgene Biomedical Endoglycosidases Sales by Geographic Area in 2024

12.5.8 Leadgene Biomedical Endoglycosidases SWOT Analysis

12.5.9 Leadgene Biomedical Recent Developments

12.6 Agilent

12.6.1 Agilent Corporation Information

12.6.2 Agilent Business Overview

12.6.3 Agilent Endoglycosidases Product Models, Descriptions and Specifications

12.6.4 Agilent Endoglycosidases Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.6.5 Agilent Recent Developments

12.7 Merck

12.7.1 Merck Corporation Information

12.7.2 Merck Business Overview

12.7.3 Merck Endoglycosidases Product Models, Descriptions and Specifications

12.7.4 Merck Endoglycosidases Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.7.5 Merck Recent Developments

12.8 MyBiosource

12.8.1 MyBiosource Corporation Information

12.8.2 MyBiosource Business Overview

12.8.3 MyBiosource Endoglycosidases Product Models, Descriptions and Specifications

12.8.4 MyBiosource Endoglycosidases Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.8.5 MyBiosource Recent Developments

12.9 Biosynth

12.9.1 Biosynth Corporation Information

12.9.2 Biosynth Business Overview

12.9.3 Biosynth Endoglycosidases Product Models, Descriptions and Specifications

12.9.4 Biosynth Endoglycosidases Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.9.5 Biosynth Recent Developments

12.10 Creative-Enzymes

12.10.1 Creative-Enzymes Corporation Information

12.10.2 Creative-Enzymes Business Overview

12.10.3 Creative-Enzymes Endoglycosidases Product Models, Descriptions and Specifications

12.10.4 Creative-Enzymes Endoglycosidases Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.10.5 Creative-Enzymes Recent Developments

12.11 Rhino Bio

12.11.1 Rhino Bio Corporation Information

12.11.2 Rhino Bio Business Overview

12.11.3 Rhino Bio Endoglycosidases Product Models, Descriptions and Specifications

12.11.4 Rhino Bio Endoglycosidases Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.11.5 Rhino Bio Recent Developments

13 Value Chain and Supply-Chain Analysis

13.1 Endoglycosidases Industry Chain

13.2 Endoglycosidases Upstream Materials Analysis

13.2.1 Raw Materials

13.2.2 Key Suppliers Market Share & Risk Assessment

13.3 Endoglycosidases Integrated Production Analysis

13.3.1 Manufacturing Footprint Analysis

13.3.2 Production Technology Overview

13.3.3 Regional Cost Drivers

13.4 Endoglycosidases Sales Channels and Distribution Networks

13.4.1 Sales Channels

13.4.2 Distributors

14 Endoglycosidases Market Dynamics

14.1 Industry Trends and Evolution

14.2 Market Growth Drivers and Emerging Opportunities

14.3 Market Challenges, Risks, and Restraints

15 Key Findings in the Global Endoglycosidases Study

16 Appendix

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.1.1 Research Programs/Design

16.1.1.2 Market Size Estimation

16.1.1.3 Market Breakdown and Data Triangulation

16.1.2 Data Source

16.1.2.1 Secondary Sources

16.1.2.2 Primary Sources

16.2 Author Details

FEATURED COMPANIES

CD BioGlyco

NEB

Ludger Ltd.

Promega

Leadgene Biomedical

Agilent

Merck

MyBioSource

Biosynth

Creative Enzymes

RHINO BIO

List of Tables

Table 1. Global Endoglycosidases Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Endoglycosidases Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Endoglycosidases Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Endoglycosidases Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Endoglycosidases Revenue by Region (2026-2031) & (US$ Million)

Table 6. Global Endoglycosidases Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (kg)

Table 7. Global Endoglycosidases Sales by Region (2020-2025) & (kg)

Table 8. Global Endoglycosidases Sales by Region (2026-2031) & (kg)

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 10. Global Endoglycosidases Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (kg)

Table 11. Global Endoglycosidases Production by Region (2020-2025) & (kg)

Table 12. Global Endoglycosidases Production by Region (2026-2031) & (kg)

Table 13. Global Endoglycosidases Sales by Manufacturers (2020-2025) & (kg)

Table 14. Global Endoglycosidases Sales Share by Manufacturers (2020-2025)

Table 15. Global Endoglycosidases Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 16. Global Endoglycosidases Revenue Market Share by Manufacturers (2020-2025)

Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 18. Global Endoglycosidases by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endoglycosidases as of 2024)

Table 19. Global Endoglycosidases Average Gross Margin (%) by Manufacturer (2020 VS 2024)

Table 20. Global Endoglycosidases Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/g)

Table 21. Key Manufacturers Endoglycosidases Manufacturing Base and Headquarters

Table 22. Global Endoglycosidases Market Concentration Ratio (CR5 and HHI)

Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 25. Global Endoglycosidases Sales by Type (2020-2025) & (kg)

Table 26. Global Endoglycosidases Sales by Type (2026-2031) & (kg)

Table 27. Global Endoglycosidases Revenue by Type (2020-2025) & (US$ Million)

Table 28. Global Endoglycosidases Revenue by Type (2026-2031) & (US$ Million)

Table 29. Global Endoglycosidases ASP by Type (2020-2031) & (US$/g)

Table 30. Technical Specifications by Key Product Type

Table 31. Global Endoglycosidases Sales by Application (2020-2025) & (kg)

Table 32. Global Endoglycosidases Sales by Application (2026-2031) & (kg)

Table 33. Endoglycosidases High-Growth Sectors Demand CAGR (2024-2031)

Table 34. Global Endoglycosidases Revenue by Application (2020-2025) & (US$ Million)

Table 35. Global Endoglycosidases Revenue by Application (2026-2031) & (US$ Million)

Table 36. Global Endoglycosidases ASP by Application (2020-2031) & (US$/g)

Table 37. Top Customers by Region

Table 38. Top Customers by Application

Table 39. North America Endoglycosidases Growth Accelerators and Market Barriers

Table 40. North America Endoglycosidases Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 41. North America Endoglycosidases Sales (kg) by Country (2020 VS 2024 VS 2031)

Table 42. Europe Endoglycosidases Growth Accelerators and Market Barriers

Table 43. Europe Endoglycosidases Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 44. Europe Endoglycosidases Sales (kg) by Country (2020 VS 2024 VS 2031)

Table 45. Asia-Pacific Endoglycosidases Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Asia-Pacific Endoglycosidases Sales (kg) by Country (2020 VS 2024 VS 2031)

Table 47. Asia-Pacific Endoglycosidases Growth Accelerators and Market Barriers

Table 48. Southeast Asia Endoglycosidases Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 49. Central and South America Endoglycosidases Investment Opportunities and Key Challenges

Table 50. Central and South America Endoglycosidases Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 51. Middle East and Africa Endoglycosidases Investment Opportunities and Key Challenges

Table 52. Middle East and Africa Endoglycosidases Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 53. CD BioGlyco Corporation Information

Table 54. CD BioGlyco Description and Major Businesses

Table 55. CD BioGlyco Product Models, Descriptions and Specifications

Table 56. CD BioGlyco Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 57. CD BioGlyco Sales Value Proportion by Product in 2024

Table 58. CD BioGlyco Sales Value Proportion by Application in 2024

Table 59. CD BioGlyco Sales Value Proportion by Geographic Area in 2024

Table 60. CD BioGlyco Endoglycosidases SWOT Analysis

Table 61. CD BioGlyco Recent Developments

Table 62. NEB Corporation Information

Table 63. NEB Description and Major Businesses

Table 64. NEB Product Models, Descriptions and Specifications

Table 65. NEB Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 66. NEB Sales Value Proportion by Product in 2024

Table 67. NEB Sales Value Proportion by Application in 2024

Table 68. NEB Sales Value Proportion by Geographic Area in 2024

Table 69. NEB Endoglycosidases SWOT Analysis

Table 70. NEB Recent Developments

Table 71. Ludger Corporation Information

Table 72. Ludger Description and Major Businesses

Table 73. Ludger Product Models, Descriptions and Specifications

Table 74. Ludger Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 75. Ludger Sales Value Proportion by Product in 2024

Table 76. Ludger Sales Value Proportion by Application in 2024

Table 77. Ludger Sales Value Proportion by Geographic Area in 2024

Table 78. Ludger Endoglycosidases SWOT Analysis

Table 79. Ludger Recent Developments

Table 80. Promega Corporation Information

Table 81. Promega Description and Major Businesses

Table 82. Promega Product Models, Descriptions and Specifications

Table 83. Promega Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 84. Promega Sales Value Proportion by Product in 2024

Table 85. Promega Sales Value Proportion by Application in 2024

Table 86. Promega Sales Value Proportion by Geographic Area in 2024

Table 87. Promega Endoglycosidases SWOT Analysis

Table 88. Promega Recent Developments

Table 89. Leadgene Biomedical Corporation Information

Table 90. Leadgene Biomedical Description and Major Businesses

Table 91. Leadgene Biomedical Product Models, Descriptions and Specifications

Table 92. Leadgene Biomedical Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 93. Leadgene Biomedical Sales Value Proportion by Product in 2024

Table 94. Leadgene Biomedical Sales Value Proportion by Application in 2024

Table 95. Leadgene Biomedical Sales Value Proportion by Geographic Area in 2024

Table 96. Leadgene Biomedical Endoglycosidases SWOT Analysis

Table 97. Leadgene Biomedical Recent Developments

Table 98. Agilent Corporation Information

Table 99. Agilent Description and Major Businesses

Table 100. Agilent Product Models, Descriptions and Specifications

Table 101. Agilent Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 102. Agilent Recent Developments

Table 103. Merck Corporation Information

Table 104. Merck Description and Major Businesses

Table 105. Merck Product Models, Descriptions and Specifications

Table 106. Merck Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 107. Merck Recent Developments

Table 108. MyBiosource Corporation Information

Table 109. MyBiosource Description and Major Businesses

Table 110. MyBiosource Product Models, Descriptions and Specifications

Table 111. MyBiosource Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 112. MyBiosource Recent Developments

Table 113. Biosynth Corporation Information

Table 114. Biosynth Description and Major Businesses

Table 115. Biosynth Product Models, Descriptions and Specifications

Table 116. Biosynth Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 117. Biosynth Recent Developments

Table 118. Creative-Enzymes Corporation Information

Table 119. Creative-Enzymes Description and Major Businesses

Table 120. Creative-Enzymes Product Models, Descriptions and Specifications

Table 121. Creative-Enzymes Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 122. Creative-Enzymes Recent Developments

Table 123. Rhino Bio Corporation Information

Table 124. Rhino Bio Description and Major Businesses

Table 125. Rhino Bio Product Models, Descriptions and Specifications

Table 126. Rhino Bio Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 127. Rhino Bio Recent Developments

Table 128. Key Raw Materials Distribution

Table 129. Raw Materials Key Suppliers

Table 130. Critical Raw Material Supplier Concentration (2024) & Risk Index

Table 131. Milestones in Production Technology Evolution

Table 132. Distributors List

Table 133. Market Trends and Market Evolution

Table 134. Market Drivers and Opportunities

Table 135. Market Challenges, Risks, and Restraints

Table 136. Research Programs/Design for This Report

Table 137. Key Data Information from Secondary Sources

Table 138. Key Data Information from Primary Sources

List of Figures

Figure 1. Endoglycosidases Product Picture

Figure 2. Global Endoglycosidases Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Endoglycosidase F1 Product Picture

Figure 4. Endoglycosidase F2 Product Picture

Figure 5. Endoglycosidase F3 Product Picture

Figure 6. Endoglycosidase H Product Picture

Figure 7. Others Product Picture

Figure 8. Global Endoglycosidases Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 9. Glycan Sequencing

Figure 10. Glycoprotein Production

Figure 11. Others

Figure 12. Endoglycosidases Report Years Considered

Figure 13. Global Endoglycosidases Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Endoglycosidases Revenue (2020-2031) & (US$ Million)

Figure 15. Global Endoglycosidases Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 16. Global Endoglycosidases Revenue Market Share by Region (2020-2031)

Figure 17. Global Endoglycosidases Sales (2020-2031) & (kg)

Figure 18. Global Endoglycosidases Sales (CAGR) by Region (2020-2031) (kg)

Figure 19. Global Endoglycosidases Sales Market Share by Region (2020-2031)

Figure 20. Global Endoglycosidases Capacity, Production and Utilization (2020-2031) & (kg)

Figure 21. Global Endoglycosidases Production Trend by Region (2020-2031) (kg)

Figure 22. Global Endoglycosidases Production Market Share by Region (2020-2031)

Figure 23. Production Capacity Enablers & Constraints

Figure 24. Endoglycosidases Production Growth Rate in North America (2020-2031) & (kg)

Figure 25. Endoglycosidases Production Growth Rate in Europe (2020-2031) & (kg)

Figure 26. Endoglycosidases Production Growth Rate in China (2020-2031) & (kg)

Figure 27. Endoglycosidases Production Growth Rate in Japan (2020-2031) & (kg)

Figure 28. Top 5 and Top 10 Manufacturers Endoglycosidases Sales Volume Market Share in 2024

Figure 29. Global Endoglycosidases Revenue Market Share Ranking (2024)

Figure 30. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 31. Endoglycosidase F1 Revenue Market Share by Manufacturer in 2024

Figure 32. Endoglycosidase F2 Revenue Market Share by Manufacturer in 2024

Figure 33. Endoglycosidase F3 Revenue Market Share by Manufacturer in 2024

Figure 34. Endoglycosidase H Revenue Market Share by Manufacturer in 2024

Figure 35. Others Revenue Market Share by Manufacturer in 2024

Figure 36. Type Eight Revenue Market Share by Manufacturer in 2024

Figure 37. Type Nine Revenue Market Share by Manufacturer in 2024

Figure 38. Global Endoglycosidases Sales Market Share by Type (2020-2031)

Figure 39. Global Endoglycosidases Revenue Market Share by Type (2020-2031)

Figure 40. Global Endoglycosidases Sales Market Share by Application (2020-2031)

Figure 41. Global Endoglycosidases Revenue Market Share by Application (2020-2031)

Figure 42. North America Endoglycosidases Sales YoY (2020-2031) & (kg)

Figure 43. North America Endoglycosidases Revenue YoY (2020-2031) & (US$ Million)

Figure 44. North America Top 5 Manufacturers Endoglycosidases Sales Revenue (US$ Million) in 2024

Figure 45. North America Endoglycosidases Sales Volume (kg) by Type (2020- 2031)

Figure 46. North America Endoglycosidases Sales Revenue (US$ Million) by Type (2020 - 2031)

Figure 47. North America Endoglycosidases Sales Volume (kg) by Application (2020-2031)

Figure 48. North America Endoglycosidases Sales Revenue (US$ Million) by Application (2020-2031)

Figure 49. US Endoglycosidases Revenue (2020-2031) & (US$ Million)

Figure 50. Canada Endoglycosidases Revenue (2020-2031) & (US$ Million)

Figure 51. Mexico Endoglycosidases Revenue (2020-2031) & (US$ Million)

Figure 52. Europe Endoglycosidases Sales YoY (2020-2031) & (kg)

Figure 53. Europe Endoglycosidases Revenue YoY (2020-2031) & (US$ Million)

Figure 54. Europe Top 5 Manufacturers Endoglycosidases Sales Revenue (US$ Million) in 2024

Figure 55. Europe Endoglycosidases Sales Volume (kg) by Type (2020-2031)

Figure 56. Europe Endoglycosidases Sales Revenue (US$ Million) by Type (2020-2031)

Figure 57. Europe Endoglycosidases Sales Volume (kg) by Application (2020-2031)

Figure 58. Europe Endoglycosidases Sales Revenue (US$ Million) by Application (2020-2031)

Figure 59. Germany Endoglycosidases Revenue (2020-2031) & (US$ Million)

Figure 60. France Endoglycosidases Revenue (2020-2031) & (US$ Million)

Figure 61. U.K. Endoglycosidases Revenue (2020-2031) & (US$ Million)

Figure 62. Italy Endoglycosidases Revenue (2020-2031) & (US$ Million)

Figure 63. Russia Endoglycosidases Revenue (2020-2031) & (US$ Million)

Figure 64. Asia-Pacific Endoglycosidases Sales YoY (2020-2031) & (kg)

Figure 65. Asia-Pacific Endoglycosidases Revenue YoY (2020-2031) & (US$ Million)

Figure 66. Asia-Pacific Top 8 Manufacturers Endoglycosidases Sales Revenue (US$ Million) in 2024

Figure 67. Asia-Pacific Endoglycosidases Sales Volume (kg) by Type (2020- 2031)

Figure 68. Asia-Pacific Endoglycosidases Sales Revenue (US$ Million) by Type (2020- 2031)

Figure 69. Asia-Pacific Endoglycosidases Sales Volume (kg) by Application (2020-2031)

Figure 70. Asia-Pacific Endoglycosidases Sales Revenue (US$ Million) by Application (2020-2031)

Figure 71. Indonesia Endoglycosidases Revenue (2020-2031) & (US$ Million)

Figure 72. Japan Endoglycosidases Revenue (2020-2031) & (US$ Million)

Figure 73. South Korea Endoglycosidases Revenue (2020-2031) & (US$ Million)

Figure 74. China Taiwan Endoglycosidases Revenue (2020-2031) & (US$ Million)

Figure 75. India Endoglycosidases Revenue (2020-2031) & (US$ Million)

Figure 76. Central and South America Endoglycosidases Sales YoY (2020-2031) & (kg)

Figure 77. Central and South America Endoglycosidases Revenue YoY (2020-2031) & (US$ Million)

Figure 78. Central and South America Top 5 Manufacturers Endoglycosidases Sales Revenue (US$ Million) in 2024

Figure 79. Central and South America Endoglycosidases Sales Volume (kg) by Type (2021-2031)

Figure 80. Central and South America Endoglycosidases Sales Revenue (US$ Million) by Type (2020-2031)

Figure 81. Central and South America Endoglycosidases Sales Volume (kg) by Application (2020-2031)

Figure 82. Central and South America Endoglycosidases Sales Revenue (US$ Million) by Application (2020-2031)

Figure 83. Brazil Endoglycosidases Revenue (2020-2025) & (US$ Million)

Figure 84. Argentina Endoglycosidases Revenue (2020-2025) & (US$ Million)

Figure 85. Middle East, and Africa Endoglycosidases Sales YoY (2020-2031) & (kg)

Figure 86. Middle East and Africa Endoglycosidases Revenue YoY (2020-2031) & (US$ Million)

Figure 87. Middle East and Africa Top 5 Manufacturers Endoglycosidases Sales Revenue (US$ Million) in 2024

Figure 88. Middle East and Africa Endoglycosidases Sales Volume (kg) by Type (2021-2031)

Figure 89. South America Endoglycosidases Sales Revenue (US$ Million) by Type (2020-2031)

Figure 90. Middle East and Africa Endoglycosidases Sales Volume (kg) by Application (2020-2031)

Figure 91. Middle East and Africa Endoglycosidases Sales Revenue (US$ Million) by Application (2020-2031)

Figure 92. GCC Countries Endoglycosidases Revenue (2020-2025) & (US$ Million)

Figure 93. Turkey Endoglycosidases Revenue (2020-2025) & (US$ Million)

Figure 94. Egypt Endoglycosidases Revenue (2020-2025) & (US$ Million)

Figure 95. South Africa Endoglycosidases Revenue (2020-2025) & (US$ Million)

Figure 96. Endoglycosidases Industry Chain Mapping

Figure 97. Regional Endoglycosidases Manufacturing Base Distribution (%)

Figure 98. Endoglycosidases Production Process

Figure 99. Regional Endoglycosidases Production Cost Structure

Figure 100. Channels of Distribution (Direct Vs Distribution)

Figure 101. Bottom-up and Top-down Approaches for This Report

Figure 102. Data Triangulation

Figure 103. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Glycosidases Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Glycobiology Enzymes Market Research Report 2024

Global Galactosidase Market Insights Forecast to 2030

Global Hyaluronidase Market Research Report 2024

Global Amyloglucosidase Market Research Report 2025

Global Carbohydrases Industrial Enzyme Market Research Report 2024

Global Carbohydrases Market Research Report 2024

Global N glycanase Market Insights Forecast to 2030

Global Endonucleases Market Research Report 2024

Global Endopeptidase Market Insights Forecast to 2030

Global Xylanase Market Research Report 2024

Beta galactosidase Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Restriction Endonucleases Product Market Research Report 2025

Global β Glucosidase Assay Kit Market Research Report 2025

Global Heparinase Enzymes Market Research Report 2024

Restriction Endonucleases Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pullulanase Market Insights Forecast to 2030

Global Carbohydrate Active Enzyme Market Research Report 2024

Global Feed Glucanase Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions